Please login to the form below

Not currently logged in
Email:
Password:

Yiruike

This page shows the latest Yiruike news and features for those working in and with pharma, biotech and healthcare.

Generic version of AZ’s Iressa launched in China

Generic version of AZ’s Iressa launched in China

Generic version of AZ’ s Iressa launched in China. Qilu Pharma’ s Yiruike licensed as first-line NSCLC treatment. ... AstraZeneca's lung cancer therapy Iressa (gefitinib) is facing generic competition in China, after Qilu Pharmaceutical's Yiruike won

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics